Cargando…

Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()

The Interamerican Society of Cardiology (IASC) Position Statement for hypertension management in Latin America is a practical and useful review of five different hypertension guidelines. Though, thiazide diuretics have been recommended as firstline option, the position statement needs to highlight d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pareek, Anil, Messerli, Franz H., Saravia, Gustavo, Mehta, Ravi Tejraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803026/
https://www.ncbi.nlm.nih.gov/pubmed/33447776
http://dx.doi.org/10.1016/j.ijchy.2020.100054
_version_ 1783635864764547072
author Pareek, Anil
Messerli, Franz H.
Saravia, Gustavo
Mehta, Ravi Tejraj
author_facet Pareek, Anil
Messerli, Franz H.
Saravia, Gustavo
Mehta, Ravi Tejraj
author_sort Pareek, Anil
collection PubMed
description The Interamerican Society of Cardiology (IASC) Position Statement for hypertension management in Latin America is a practical and useful review of five different hypertension guidelines. Though, thiazide diuretics have been recommended as firstline option, the position statement needs to highlight differences within the thiazide class. Chlorthalidone is structurally and pharmacokinetically distinct from thiazide-type iuretics like hydrochlorothiazide with a longer half-life and 24-h anti-hypertensive effect. It has been shown to reduce cardiovascular morbidity and mortality in several landmark studies evaluating anti-hypertensives.
format Online
Article
Text
id pubmed-7803026
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78030262021-01-13 Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics() Pareek, Anil Messerli, Franz H. Saravia, Gustavo Mehta, Ravi Tejraj Int J Cardiol Hypertens Correspondence The Interamerican Society of Cardiology (IASC) Position Statement for hypertension management in Latin America is a practical and useful review of five different hypertension guidelines. Though, thiazide diuretics have been recommended as firstline option, the position statement needs to highlight differences within the thiazide class. Chlorthalidone is structurally and pharmacokinetically distinct from thiazide-type iuretics like hydrochlorothiazide with a longer half-life and 24-h anti-hypertensive effect. It has been shown to reduce cardiovascular morbidity and mortality in several landmark studies evaluating anti-hypertensives. Elsevier 2020-09-19 /pmc/articles/PMC7803026/ /pubmed/33447776 http://dx.doi.org/10.1016/j.ijchy.2020.100054 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Pareek, Anil
Messerli, Franz H.
Saravia, Gustavo
Mehta, Ravi Tejraj
Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()
title Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()
title_full Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()
title_fullStr Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()
title_full_unstemmed Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()
title_short Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()
title_sort interamerican society of cardiology (iasc) position statement: chlorthalidone vs. thiazide-type diuretics()
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803026/
https://www.ncbi.nlm.nih.gov/pubmed/33447776
http://dx.doi.org/10.1016/j.ijchy.2020.100054
work_keys_str_mv AT pareekanil interamericansocietyofcardiologyiascpositionstatementchlorthalidonevsthiazidetypediuretics
AT messerlifranzh interamericansocietyofcardiologyiascpositionstatementchlorthalidonevsthiazidetypediuretics
AT saraviagustavo interamericansocietyofcardiologyiascpositionstatementchlorthalidonevsthiazidetypediuretics
AT mehtaravitejraj interamericansocietyofcardiologyiascpositionstatementchlorthalidonevsthiazidetypediuretics